Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug Adcetris and a tablet formulation of Roche’s R ...
Is Novartis AG (NVS) the Best Foreign Dividend Stock to Buy According to Analysts?
We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are ...
MM&M22h
Rx Rundown: Novartis, Abcuro, SpringWorks Therapeutics and more
RxTechExam and the Pennsylvania Pharmacists Association announced a strategic partnership. Roche’s $8 billion InterMune acquisition has been handed to a specialty pharmaceutical company, Cayman ...
U.S. private equity groups invested billion in ByteDance data centers, FT says
U.S. private equity groups have invested billions in data centers serving TikTok owner ByteDance, Kaye Wiggins, Eleanor Olcott, Owen Walker, ...
pharmaphorum20h
A history of Novartis
Novartis has agreed to buy Anthos from private equity firm Blackstone for $3.1 billion, taking Factor XI inhibitor abelacimab back in-house. Sales & Marketing Sponsored ...
Blackstone plans to finance NYC office tower stake with $800M loan - report
Blackstone (NYSE:BX) is planning to secure an $800M loan to finance its acquisition of a stake in a 50-story office building at 1345 Avenue of the Americas in New York City, according to a media ...
pharmaphorum20h
Novartis bid to block generic Entresto in US suffers setback
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...